Related Experiment Video
Updated: Jul 26, 2025

Saturated Fatty Acids Induce Ceramide-associated Macrophage Cell Death
Published on: October 31, 2017
Fatty acid binding proteins in multiple myeloma.
Camila Diedrich1, Mina Maksimos1, Abdel Kareem Azab1
1Department of Biomedical Engineering, University of Texas Southwestern, 5323 Harry Hines Blvd., Suite K2.304B, Dallas, TX 75390, USA.
Fatty acid binding proteins (FABPs) are a novel metabolic target in multiple myeloma (MM). Inhibiting FABPs may offer a new therapeutic strategy for this hematologic malignancy.
Area of Science:
- Oncology
- Molecular Biology
- Metabolism
Background:
- Fatty acid binding proteins (FABPs) facilitate fatty acid (FA) transport for cellular energy.
- FABP inhibition has shown efficacy in suppressing solid tumor proliferation.
- Multiple myeloma (MM) is characterized by disrupted protein metabolism and high proteasome activity, with proteasome inhibitors improving treatment outcomes.
Purpose of the Study:
- To investigate the role of FABPs as a novel metabolic pathway in multiple myeloma.
- To explore the potential of targeting FABPs for therapeutic applications in MM.
Main Methods:
- The study focuses on the metabolic pathways in multiple myeloma.
- Investigated the role of fatty acid binding proteins (FABPs) in MM biology.
Main Results:
- Recent discoveries highlight FABPs as a novel metabolic pathway in multiple myeloma.
- This finding has significant implications for understanding MM biology.
Conclusions:
- Fatty acid binding proteins (FABPs) represent a promising new therapeutic target for multiple myeloma.
- Targeting FABPs could impact the future treatment strategies for MM.
More Related Videos
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Related Concept Videos
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
Drug Distribution: Plasma Protein Binding
Drug Distribution: Tissue Binding
For...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Lipids as Anchors
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...